company background image
NDRA

ENDRA Life Sciences NasdaqCM:NDRA Stock Report

Last Price

US$4.20

Market Cap

US$13.3m

7D

4.7%

1Y

-64.8%

Updated

03 Feb, 2023

Data

Company Financials +

ENDRA Life Sciences Inc.

NasdaqCM:NDRA Stock Report

Mkt Cap: US$13.3m

NDRA Stock Overview

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound.

NDRA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

New

Notes are coming soon

ENDRA Life Sciences Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ENDRA Life Sciences
Historical stock prices
Current Share PriceUS$4.20
52 Week HighUS$12.98
52 Week LowUS$3.16
Beta0.95
1 Month Change0.86%
3 Month Change-2.33%
1 Year Change-64.77%
3 Year Change-85.00%
5 Year Change-93.81%
Change since IPO-94.62%

Recent News & Updates

ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks

Sep 29

Recent updates

ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks

Sep 29

ENDRA Life Sciences receives European patent for TAEUS system

Aug 24

Endra Life Sciences Q2 2022 Earnings Preview

Aug 12

We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

Aug 08
We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

Nov 18
We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully

Jul 19
We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully

ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer

Jun 15

ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology

Jan 13

ENDRA Life Sciences renews GE Healthcare collaboration agreement

Dec 21

Endra Life prices $5M-share offering

Dec 16

Endra Life Sciences EPS beats by $0.02

Nov 16

Shareholder Returns

NDRAUS Medical EquipmentUS Market
7D4.7%2.5%1.7%
1Y-64.8%-10.2%-9.1%

Return vs Industry: NDRA underperformed the US Medical Equipment industry which returned -10.2% over the past year.

Return vs Market: NDRA underperformed the US Market which returned -9.1% over the past year.

Price Volatility

Is NDRA's price volatile compared to industry and market?
NDRA volatility
NDRA Average Weekly Movement15.7%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.8%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: NDRA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: NDRA's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
200722Francois Michelonhttps://www.endrainc.com

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person’s body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.

ENDRA Life Sciences Inc. Fundamentals Summary

How do ENDRA Life Sciences's earnings and revenue compare to its market cap?
NDRA fundamental statistics
Market CapUS$13.27m
Earnings (TTM)-US$12.99m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NDRA income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$12.99m
Earnings-US$12.99m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-4.11
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio2.6%

How did NDRA perform over the long term?

See historical performance and comparison